# DLA Awards Kindeva $226M St. Louis ATNAA Contract

The Defense Logistics Agency awarded Meridian Medical Technologies, Kindeva Drug Delivery’s global health security division, a sole-source contract valued at up to **$226 million** to manufacture and supply more than three million FDA-approved Antidote Treatment Nerve Agent Autoinjectors (ATNAA) for U.S. military personnel and other federal customers. The award, dated October 15, 2026, will be manufactured at Kindeva’s St. Louis campus and supports federal chemical-threat medical-countermeasure readiness; it is an award, not an open solicitation.

- The sole-source award identifies Meridian as the supplier, so competing firms should not treat this as an active bid opportunity.
- The procurement signals sustained demand for domestic sterile injectable, pharmaceutical fill-finish, and drug-device manufacturing capacity.
- Manufacturers and supply-chain firms can assess whether they can support Kindeva’s production or related medical-countermeasure supply needs; the signals do not identify specific subcontracting opportunities or contacts.

**Jurisdictions:** federal
**Industries:** Defense & Military, Healthcare
**Topics:** Grants & Funding, Emergency Response
**Published:** October 17, 2026

### Government Entities
- Defense Logistics Agency (DLA)
- Department of Defense (DoD)
- U.S. Food and Drug Administration (FDA)

### Vendors
- Meridian Medical Technologies, LLC (Sole-source awardee and supplier)
- Kindeva Drug Delivery (Parent company of the awardee and manufacturer)

### Key Quotes
> Following the recent visit from the DLA to our St. Louis facility, we were proud to showcase our proven expertise in fill finish and highlight how our team is delivering critical medical countermeasures (MCM).
> — David Stevens, CEO of Kindeva Drug Delivery

### Sources
- [Kindeva lands $226M defense contract to supply nerve agent antidote in US! #healthcare #defense #nerveagent #America 
https://t.co/Wc8qhn6wn6 https://t.co/svm8ErTvXj](https://x.com/Alpha_Bronze/status/2111055805629800665) - twitter-defense
- [Kindeva Drug Delivery’s global health security division, Meridian Medical Technologies, LLC, has been awarded a $226 million contract by the Defense Logistics Agency (DLA) to manufacture and supply Antidote Treatment Nerve Agent Autoinjectors (ATNAA). ➡️ https://t.co/lYvSFpkyIF
 ](https://x.com/ContractPharma/status/2110793017422430570) - twitter-defense
- [Kindeva secures $226m US defence contract for nerve agent antidote autoinjectors](https://manufacturingchemist.com/kindeva-226m-us-defence-contract-nerve-antidote-autoinjectors) - Manufacturing Chemist